Literature DB >> 28772209

Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.

Seema Patel1, Abdur Rauf2, Haroon Khan3, Tareq Abu-Izneid4.   

Abstract

Renin-angiotensin-aldosterone system (RAAS) is a vital system of human body, as it maintains plasma sodium concentration, arterial blood pressure and extracellular volume. Kidney-secreted renin enzyme acts on its substrate to form angiotensin II, a versatile effector peptide hormone. Every organ is affected by RAAS activation and the resultant hypertension, cell proliferation, inflammation, and fibrosis. The imbalance of renin and angiotensin II can result in an overwhelming number of chronic and acute diseases. RAAS is influenced by other enzymes, hormones, pumps and signaling pathways, hence, this review discusses important facets of this system, its crosstalk with other crucial factors like estrogen, thyroid, cortisol, kallikrein-kinin system, Wnt/β-catenin signaling, and sodium-potassium pump. The nexus of RAAS with the above-discussed systems was scantily explored before. So, this review furnishes a new perspective in comprehension of inflammation diseases. It is followed by the formulation of hypotheses, which can contribute to better management of an array of pathologies plaguing mankind. Manipulation of RAAS, by bending it towards ACE2 expression can regulate endocrine functions, which can be critical for a number of pathological management. Dietary intervention can restore RAAS to normalcy.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aldosterone; Angiotensin II; Hypertension; Renin; Vasopressin

Mesh:

Substances:

Year:  2017        PMID: 28772209     DOI: 10.1016/j.biopha.2017.07.091

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  113 in total

1.  Decipher the complexity of cis-regulatory regions by a modified Cas9.

Authors:  Steven Kirchner; Stefanie Reuter; Anika Westphal; Ralf Mrowka
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

Review 2.  The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications.

Authors:  Christos Yapijakis; Iphigenia Gintoni; Maria Adamopoulou
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

3.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

4.  Targeting the renin-angiotensin-aldosterone system in fibrosis.

Authors:  Mohammad AlQudah; Taben M Hale; Michael P Czubryt
Journal:  Matrix Biol       Date:  2020-05-16       Impact factor: 11.583

5.  Expression and Function of Mas-Related G Protein-Coupled Receptor D and Its Ligand Alamandine in Retina.

Authors:  Ping Zhu; Amrisha Verma; Tuhina Prasad; Qiuhong Li
Journal:  Mol Neurobiol       Date:  2019-08-07       Impact factor: 5.590

6.  Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Authors:  Iuliia Polina; Mark Domondon; Rebecca Fox; Anastasia V Sudarikova; Miguel Troncoso; Valeriia Y Vasileva; Yuliia Kashyrina; Monika Beck Gooz; Ryan S Schibalski; Kristine Y DeLeon-Pennell; Wayne R Fitzgibbon; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

Review 7.  Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.

Authors:  Fernando Pedro de Souza-Neto; Melissa Carvalho Santuchi; Mario de Morais E Silva; Maria José Campagnole-Santos; Rafaela Fernandes da Silva
Journal:  Curr Hypertens Rep       Date:  2018-03-14       Impact factor: 5.369

8.  PKCδ Mediates Mineralocorticoid Receptor Activation by Angiotensin II to Modulate Smooth Muscle Cell Function.

Authors:  Qing Lu; Ana P Davel; Adam P McGraw; Sitara P Rao; Brenna G Newfell; Iris Z Jaffe
Journal:  Endocrinology       Date:  2019-09-01       Impact factor: 4.736

9.  [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV].

Authors:  Yongzhi Lun; Ben Liu; Wen Dong; Jie Sun; Linghong Pan
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

10.  Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice.

Authors:  Masato Narita; Kenji Hanada; Yosuke Kawamura; Hiroaki Ichikawa; Shuntaro Sakai; Yoshikazu Yokono; Maiko Senoo; Noritomo Narita; Michiko Shimada; Tomohiro Osanai; Ken Okumura; Hirofumi Tomita
Journal:  Hypertens Res       Date:  2021-07-20       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.